奥洛兹美医疗与福泰制药就Hypercon™技术达成全球合作与授权协议

美股速递
Apr 07

奥洛兹美医疗(Halozyme Therapeutics)宣布,已与福泰制药(Vertex Pharmaceuticals)就其专有的Hypercon™技术达成一项全球性的合作与许可协议。此项合作旨在利用Hypercon技术平台,共同探索和开发新的治疗方案。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10